Table 1.
Clinical characteristics of participating childhood cancer survivors (N = 50).
| n (%) | |
|---|---|
| Gender | |
| Female | 25 (50) |
| Cancer type | |
| Leukamia | 13 (26) |
| Lymphoma | 12 (24) |
| Central nervous system neoplasms | 7 (14) |
| Renal tumors | 4 (8) |
| Liver tumors | 1 (2) |
| Malignant bone tumors | 3 (6) |
| Soft tissue sarcomas | 5 (10) |
| Germ cell tumors | 5 (10) |
| Relapse | |
| Yes | 4 (8) |
| Secondary malignancya | |
| Yes | 3 (6) |
| Age at diagnosis [years] (median [IQR]) | 10.1 [3.6–12.6] |
| 0–5 years | 16 (32) |
| 6–10 years | 9 (18) |
| 11–15 years | 21 (42) |
| 16–18 years | 4 (8) |
| Follow up time since diagnosis [years] (median [IQR]) | 16.1 [12.6–19.5] |
| 5–10 years | 7 (14) |
| 11–15 years | 15 (30) |
| 16–20 years | 16 (32) |
| 21–25 years | 9 (18) |
| 26–30 years | 3 (6) |
aSecondary malignancies: papillary thyroid carcinoma (n = 1), pilocytic astrocytoma in a patient with neurofibromatosis type 1 (n = 1), basal cell carcinoma (n = 1); IQR, interquartile range.